Return to content in this issue

 

Revisited the Impact of Misdiagnosed Drug Hypersensitivity in Hospitalized Patients: A 10-Year Perspective

Bernaola J1*, Otal-Buesa M1*, Barroso B1,2, Valverde-Monge M1,2, Sastre J1,2

1Allergy Unit, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
2CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain
*Both authors contributed equally

J Investig Allergol Clin Immunol 2025; Vol. 35(3)
doi: 10.18176/jiaci.1056

Key words: Drug hypersensitivity, Misdiagnosis, Hospitalized patients, Economic burden, Treatment costs